Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators. Diener HC, et al. N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959. N Engl J Med. 2019. PMID: 31091372 Clinical Trial.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Diener HC, et al. Lancet. 2004 Jul 24-30;364(9431):331-7. doi: 10.1016/S0140-6736(04)16721-4. Lancet. 2004. PMID: 15276392 Clinical Trial.
Clopidogrel for the secondary prevention of stroke.
Diener HC, Ringleb PA, Savi P. Diener HC, et al. Expert Opin Pharmacother. 2005 May;6(5):755-64. doi: 10.1517/14656566.6.5.755. Expert Opin Pharmacother. 2005. PMID: 15934902 Review.
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csányi A, Schneider D, Klingelhöfer J, Brom J, Weidinger G; PROTECT Trial Group. Diener HC, et al. Stroke. 2006 Jan;37(1):139-44. doi: 10.1161/01.STR.0000195182.67656.ee. Epub 2005 Nov 23. Stroke. 2006. PMID: 16306456 Clinical Trial.
NXY-059 for acute ischemic stroke.
Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. Lees KR, et al. Among authors: diener hc. N Engl J Med. 2006 Feb 9;354(6):588-600. doi: 10.1056/NEJMoa052980. N Engl J Med. 2006. PMID: 16467546 Free article. Clinical Trial.
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC, Sacco R, Yusuf S; Steering Committee; PRoFESS Study Group. Diener HC, et al. Cerebrovasc Dis. 2007;23(5-6):368-80. doi: 10.1159/000100105. Epub 2007 Feb 26. Cerebrovasc Dis. 2007. PMID: 17337887 Clinical Trial.
NXY-059 for the treatment of acute ischemic stroke.
Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U; SAINT II Trial Investigators. Shuaib A, et al. Among authors: diener hc. N Engl J Med. 2007 Aug 9;357(6):562-71. doi: 10.1056/NEJMoa070240. N Engl J Med. 2007. PMID: 17687131 Free article. Clinical Trial.
1,374 results